108 related articles for article (PubMed ID: 3559882)
1. Conjugation of salicylamide in the intestinal wall of dogs and rabbits.
Podder SK; Nakashima M; Nakamura T; Sasaki H; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1986 Nov; 9(11):917-22. PubMed ID: 3559882
[TBL] [Abstract][Full Text] [Related]
2. Some quantitative evaluation of first-pass metabolism of salicylamide in rabbit and rat.
Shibasaki J; Konishi R; Koike M; Imamura A; Sueyasu M
J Pharmacobiodyn; 1981 Feb; 4(2):91-100. PubMed ID: 7277202
[TBL] [Abstract][Full Text] [Related]
3. An assessment of indomethacin-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1261-5. PubMed ID: 1394644
[TBL] [Abstract][Full Text] [Related]
4. An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):815-8. PubMed ID: 1611698
[TBL] [Abstract][Full Text] [Related]
5. An assessment of mucosal damage in vivo: effect of oral pretreatment with 5-fluorouracil on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1011-5. PubMed ID: 1525929
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral pretreatment with indomethacin on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Seki N; Sasaki H; Shibasaki J
J Pharmacobiodyn; 1988 Sep; 11(9):620-4. PubMed ID: 3216283
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
8. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
9. Salicylamide pharmacokinetics in healthy males: dietary effect.
Morad AR
Biopharm Drug Dispos; 1982; 3(2):175-83. PubMed ID: 7104464
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.
Waschek JA; Fielding RM; Pond SM; Rubin GM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1985 Aug; 234(2):431-4. PubMed ID: 4020679
[TBL] [Abstract][Full Text] [Related]
11. Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes.
Koike M; Sugeno K; Hirata M
J Pharm Sci; 1981 Mar; 70(3):308-11. PubMed ID: 7264898
[TBL] [Abstract][Full Text] [Related]
12. First-pass elimination of salicylamide in man following oral and rectal administration.
de Boer AG; Breimer DD; Gubbens-Stibbe JM; Bosma A
Biopharm Drug Dispos; 1983; 4(4):321-30. PubMed ID: 6689276
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
Xu X; Selick P; Pang KS
J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
[TBL] [Abstract][Full Text] [Related]
14. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Xu X; Hirayama H; Pang KS
Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
[TBL] [Abstract][Full Text] [Related]
16. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
Tirona RG; Pang KS
Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815
[TBL] [Abstract][Full Text] [Related]
17. Availability of plasma sulfate for conjugation of salicylamide in dogs.
Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
Biochem Pharmacol; 1986 Feb; 35(3):544-6. PubMed ID: 3947388
[No Abstract] [Full Text] [Related]
18. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.
Xu X; Pang KS
J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738
[TBL] [Abstract][Full Text] [Related]
19. Salycylamide glucuronide formation in liver disease and its change by drugs.
Adachi Y; Wakisaka G; Yamamoto T
Gastroenterol Jpn; 1975; 10(2):120-31. PubMed ID: 10219
[TBL] [Abstract][Full Text] [Related]
20. Splanchnic and intestinal uptake and formation of estriol and estriol conjugates in the dog in vivo.
Collins DC; Balikian HM; Preedy JR
Steroids; 1976 Nov; 28(5):597-612. PubMed ID: 189463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
